Skip to main content
Premium Trial:

Request an Annual Quote

Natrix Separations Raises $19M in Series B Financing

NEW YORK (GenomeWeb News) – Natrix Separations, a Burlington, Ontario-based manufacturer of membrane-based disposable chromatography products, has raised $19 million in a Series B financing, the firm announced last night.
The firm said it would use the funds to complete construction of its ISO 900-compliant commercial manufacturing facility, and to support commercialization of its portfolio of separation products based on its adsept technology. That technology enables end users to rapidly and selectively capture specific target molecules from a broad range of feed streams, Natrix said.
The round of financing was led by Cupertino, Calif.-based DE Shaw Venture Capital and included existing investors Canadian Medical Discoveries Fund, which is managed by a unit of Jovian Capital, and BDC Venture Capital, which is the venture capital arm of the Business Development Bank of Canada.
As part of the financing, Alex Wong, a managing director of DE Shaw, will join Natrix’s board of directors.
“Natrix is a rare company that has created technology to enable a new generation of cost-effective, high performance products ranging from therapeutic drugs to nutraceuticals and ultrapure drinking water,” Wong said in a statement.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.